bmy 7378 has been researched along with ro 70-0004 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Li, MY; Tsai, KC; Xia, L | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
1 review(s) available for bmy 7378 and ro 70-0004
| Article | Year |
|---|---|
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
2 other study(ies) available for bmy 7378 and ro 70-0004
| Article | Year |
|---|---|
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Evaluation, Preclinical; Expert Systems; Humans; Models, Molecular; Receptors, Adrenergic, alpha-1; Software; Structure-Activity Relationship | 2005 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |